18F-FDG PET/CT as an Indicator of Progression-Free and Overall Survival in Osteosarcoma
暂无分享,去创建一个
Roland L Bassett | Edith M Marom | O. Mawlawi | E. Rohren | H. Macapinlac | V. Lewis | R. Bassett | E. Marom | Osama R Mawlawi | C. Costelloe | J. Madewell | N. Fitzgerald | A. Raymond | P. Anderson | R. Harrell | John E Madewell | Eric M Rohren | Nancy E Fitzgerald | Homer A Macapinlac | Colleen M Costelloe | Valerae O Lewis | Valerae O. Lewis | A Kevin Raymond | Peter M Anderson | Robyn K Harrell
[1] J. Edeiken,et al. Small cell osteosarcoma. A clinicopathologic study of 27 cases , 1989, Cancer.
[2] J. Eary,et al. Evaluation of chemotherapy response in pediatric bone sarcomas by [F‐18]‐fluorodeoxy‐D‐glucose positron emission tomography , 2002, Cancer.
[3] John L. Humm,et al. Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis. , 1999, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.
[4] Andreas Bockisch,et al. Segmentation of PET volumes by iterative image thresholding. , 2007, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[5] F. Bertoni,et al. Dedifferentiated parosteal osteosarcoma: The experience of the Rizzoli Institute , 2005, Cancer.
[6] W. Roa,et al. Iterative threshold segmentation for PET target volume delineation. , 2007, Medical physics.
[7] A. Ho,et al. Large Institutional Experience with Dose-Intensive Chemotherapy and Stem Cell Support in the Management of Sarcoma Patients , 2008, Oncology.
[8] F. Sim,et al. Malignant bone tumors. , 2001, Instructional course lectures.
[9] O. Schober,et al. Evaluation of Chemotherapy Response in Primary Bone Tumors with F-18 FDG Positron Emission Tomography Compared with Histologically Assessed Tumor Necrosis , 2000, Clinical nuclear medicine.
[10] P. Picci,et al. Prognostic and therapeutic relevance of HER2 expression in osteosarcoma and Ewing's sarcoma. , 2005, European journal of cancer.
[11] Dafydd G. Thomas,et al. Primary versus radiation‐associated craniofacial osteosarcoma , 2006, Cancer.
[12] G. Rosen,et al. Survival, prognosis, and therapeutic response in osteogenic sarcoma. The memorial hospital experience , 1992, Cancer.
[13] W. Winkelmann,et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] J. Cullen,et al. Improved Survival in Primary Nonmetastatic Pediatric Osteosarcoma of the Extremity , 2005, Clinical orthopaedics and related research.
[15] S. Ferrari,et al. Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol: an updated report. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] N. Jaffe,et al. Conventional and dedifferentiated parosteal osteosarcoma. Diagnosis, treatment, and outcome. , 1996, Cancer.
[17] N. Daw,et al. Telangiectatic osteosarcoma: The St. Jude Children's Research Hospital's experience , 2007, Cancer.
[18] Aswin L Hoffmann,et al. Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer. , 2007, International journal of radiation oncology, biology, physics.
[19] Ukihide Tateishi,et al. Bone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET/CT. , 2008, Radiology.
[20] S. Reske,et al. Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] Hollinger,et al. Response of Osteosarcoma to Chemotherapy. Evaluation with F-18 FDG-PET Scans. , 2000, Clinical positron imaging : official journal of the Institute for Clinical P.E.T.
[22] M. Link,et al. Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] Y. Dobashi,et al. Prognostic significance of 18F-FDG uptake in primary osteosarcoma after but not before chemotherapy: a possible association with autocrine motility factor/phosphoglucose isomerase expression , 2008, Clinical & Experimental Metastasis.
[24] M. Gebhardt,et al. Survival Data for 648 Patients with Osteosarcoma Treated at One Institution , 2004, Clinical orthopaedics and related research.
[25] David Schuster,et al. Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer. , 2005, International journal of radiation oncology, biology, physics.
[26] C. Rübe,et al. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[27] J. Wunder,et al. Prognosis of Radiation-induced Bone Sarcoma is Similar to Primary Osteosarcoma , 2006, Clinical orthopaedics and related research.
[28] Anne Bol,et al. Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[29] H. Steinert,et al. Therapy response evaluation in malignant pleural mesothelioma with integrated PET-CT imaging. , 2005, Lung cancer.
[30] Joel Karp,et al. Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[31] John L. Humm,et al. Use of PET to monitor the response of lung cancer to radiation treatment , 2000, European Journal of Nuclear Medicine.
[32] D. Yan,et al. Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer. , 2007, International journal of radiation oncology, biology, physics.
[33] S. Bielack,et al. [Scintigraphic follow-up of osteosarcoma during neoadjuvant chemotherapy. Results of the cooperative osteosarcoma study of the Society for Pediatric Oncology]. , 1988, Nuklearmedizin. Nuclear medicine.
[34] N. Jaffe,et al. Effect of cumulative courses of intraarterial cis‐diamminedichloroplatin‐ii on the primary tumor in osteosarcoma , 1989, Cancer.
[35] R. Grimer,et al. Pre- and post-chemotherapy alkaline phosphatase levels as prognostic indicators in adults with localised osteosarcoma. , 2005, European journal of cancer.
[36] T. Peabody,et al. Staging of Primary Malignancies of Bone , 2006, CA: a cancer journal for clinicians.
[37] O. Schober,et al. Prognostic significance of (18)F-FDG and (99m)Tc-methylene diphosphonate uptake in primary osteosarcoma. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[38] H. Gerth,et al. Significant Benefit of Multimodal Imaging: PET/CT Compared with PET Alone in Staging and Follow-up of Patients with Ewing Tumors , 2007, Journal of Nuclear Medicine.
[39] A. N. Mirza,et al. Outcome of Postradiation Osteosarcoma Does Not Correlate with Chemotherapy Response , 2006, Clinical orthopaedics and related research.
[40] W. Enneking,et al. Current concepts review. The surgical staging of musculoskeletal sarcoma. , 1980, The Journal of bone and joint surgery. American volume.
[41] S. Larson,et al. Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer. , 2004, Journal of the American College of Surgeons.
[42] F. Sim,et al. Small cell osteosarcoma of bone , 1997, Cancer.
[43] J. Murray,et al. Osteosarcoma chemotherapy effect: a prognostic factor. , 1987, Seminars in diagnostic pathology.